All blog posts
Total 14 results for
Showing 12 out of 14 results
16 dezembro 2019
RATIFICATION OF THE UPC AGREEMENT IN SIGHT? GERMAN CONSTITUTIONAL DECISION LIKELY EARLY IN 2020
04 dezembro 2019
European pharma patent law update
12 novembro 2019
Harnessing the power of diversity in IP
22 outubro 2019
Patent and Pharma Update, October 2019
03 outubro 2019
Open Innovation: Getting the IP right in collaborations
18 setembro 2019
CJEU refuses UK High Court's request for preliminary ruling on SPC applications based on third-party MAs, on account of referred question being "hypothetical" (C-239/19 Eli Lilly v Genentech)
11 setembro 2019
Updated HSF Legal Guide to Brexit published (including IP and Pharma sections)
11 julho 2019
Open Innovation: Collaborate to Innovate
10 junho 2019
New German Trade Secrets Act Enacted
08 maio 2019
Data Assets - Protecting and Driving Value in a Digital Age
05 abril 2019
Patent and Pharma Update - April 2019
25 março 2019
The Court of Justice of the European Union holds that Supplementary Protection Certificates cannot be obtained for new formulations of previously approved active ingredients in Abraxis (Case C-443/17)
Showing 12 out of 14 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London